UNLIMITED TURBO LONG - STRYKER CORP. Stock

Certificat

DE000PH7VYW8

Delayed Deutsche Boerse AG 06:21:10 2024-06-03 am EDT
13.52 EUR +3.76% Intraday chart for UNLIMITED TURBO LONG - STRYKER CORP.
1 month-1.59%
3 months-9.70%
Date Price Change
24-06-03 13.52 +3.76%
24-05-31 13.03 -1.14%
24-05-30 13.18 -1.27%
24-05-29 13.35 +2.61%
24-05-28 13.01 +0.93%

Delayed Quote Deutsche Boerse AG

Last update June 03, 2024 at 06:21 am EDT

More quotes

Static data

Product typeKnock-Out sin Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PH7VYW
ISINDE000PH7VYW8
Date issued 2021-12-06
Strike 199.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 7
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 15.38
Lowest since issue 1.82
Spread 0.15
Spread %1.10%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
341.1 USD
Average target price
373.1 USD
Spread / Average Target
+9.38%
Consensus